Following the decision of the Colorado PDAB to implement an upper payment limit (UPL) for the drug Enbrel, the EACH/PIC Coalition sent a letter to members of the Colorado Legislature […]
The EACH/PIC Coalition submitted comments to the Oregon PDAB in advance of their October meeting on policies proposed for the annual report to the Oregon legislature. The letter followed up
By Sara Wilson Democratic leaders, health care providers and consumer advocates praised a Colorado board’s decision last week to cap the price of a prescription drug used to treat rheumatoid
By John Ingold An obscure Colorado board took an unprecedented step last week in an attempt to control the prices that patients pay for their medicines. … “The board has
By Luke Zarzecki The Colorado Prescription Drug Affordability Board voted Friday (Oct. 3) to set an upper payment limit (UPL) on Amgen’s Enbrel that will take effect on Jan. 1,
By Celine Castronuovo Amgen Inc.‘s blockbuster biologic Enbrel will be the first product to face a state-imposed health plan payment cap under a landmark vote by a key Colorado affordability
October 3, 2025 Tiffany Westrich-Robertson, EACH/PIC Coalition founder and person living with an autoimmune condition, issued the following statement on today’s upper payment limit decision: “We are disappointed that the
The EACH/PIC Coalition submitted comments to the Colorado PDAB in advance of their fourth rulemaking hearing to implement an upper payment limit for Enbrel. The letter urges the board not
The EACH/PIC Coalition submitted a comment letter to the Washington Prescription Drug Affordability Board (PDAB) sharing best practices on patient engagement and giving specific feedback on draft surveys released by
The EACH/PIC Coalition submitted a comment letter to the Minnesota Prescription Drug Affordability Board (PDAB) providing input for the board on patient engagement, sharing best practices and lessons learned in
